Research
-
Completed
November 2014 - August 2015
Do environmental changes to DNA play a part in the risk of getting AMD?
Gathering the information we need to reduce the risk of severe sight loss.
-
Completed
April 2015 - August 2015
Overcoming the barriers to gene therapy in Leber congenital amaurosis
Finding out which patients might benefit in a step towards clinical trials.
-
Completed
October 2012 - September 2015
A new technique for keeping artificial lenses clear: it works, but how?
Understanding how lens cells behave after cataract surgery
-
Completed
October 2019 - July 2023
MicroRNA based therapeutics to treat ocular fibrosis in glaucoma.
A study to develop miRNA-based therapeutics to treat TGFβ induced fibrosis to improve the treatment of glaucoma medically and surgically.
-
Completed
October 2018 - May 2023
Delivering 'drop-based' immunotherapeutic therapy to the choroid and retina: a new approach in uveitis and age-related macular degeneration
Researchers aim to develop medicines that could be given in ‘drop’ form rather than through the usual method of eye injection.
-
Starting soon
November 2023 - November 2026
A randomised feasibility study of imaging-based uveitis screening for children with juvenile idiopathic arthritis
-
-
Active
October 2023 - September 2026
RGC structure and mitochondrial function in LHON: the paradox of recovery and an extended therapeutic window.
-
Active
January 2023 - January 2026
Analysing DNA to provide accurate diagnoses and help predict the outcome of retinoblastoma (Rb)
Researchers are investigating eye fluid samples from retinoblastoma patients to make the test as reliable and cost efficient as possible so it can be introduced into clinical service.